Comparative Evaluation of the Efficacy and Safety of 0.5% Hyperbaric Ropivacaine Versus 0.5% Hyperbaric Bupivacaine in Spinal Anaesthesia-150 Cases

Key Points

• The aim is to compare the efficacy and safety of hyperbaric ropivacaine and bupivacaine for spinal anaesthesia.
• 150 cases were evaluated through a randomized trial design.
• Patients received either 0.5% hyperbaric ropivacaine or 0.5% hyperbaric bupivacaine for spinal anaesthesia.
• Efficacy and safety outcomes were measured following the administration.
• Ropivacaine showed a median onset time of 6.2 minutes compared to bupivacaine's 6.8 minutes.
• Safety profiles indicated fewer side effects in the ropivacaine group with a statistically significant difference (p<0.05).
• Overall patient satisfaction was higher in the ropivacaine group, indicating improved efficacy.